Evidence map›Paper›PMID 34296180›Full record

ArticleCerebral cortex communications2021

Immunohistological Examination of AKT Isoforms in the Brain: Cell-Type Specificity That May Underlie AKT's Role in Complex Brain Disorders and Neurological Disease.

Josien Levenga, Helen Wong, Ryan Milstead, Lauren LaPlante, Charles A Hoeffer

Open access · hybridAbstract read
In one paragraph

Article in Cerebral cortex communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Selective orexin receptor cross-over treatment increases resilience and expression of neuroplastic signaling genes.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Josien LevengaInstitute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
Helen WongInstitute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
Ryan MilsteadInstitute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
Lauren LaPlanteInstitute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
Charles A HoefferInstitute for Behavioral Genetics, University of Colorado Boulder, Boulder, CO 80303, USA.
University of Colorado Boulder · US

Funding

Sleep Disruption and Alzheimer's Disease PathologyRF1AG064465 · NIA · UNIVERSITY OF COLORADO · PI HOEFFER, CHARLES A, LINK, CHRISTOPHER D. · 2019 to 2022
$4.4M
Akt regulation of synaptic plasticity and behaviorR01NS086933 · NINDS · UNIVERSITY OF COLORADO · PI HOEFFER, CHARLES A · 2015 to 2019
$1.8M
University of Colorado Interdisciplinary Training in Demography and GeneticsT32AG052371 · NIA · UNIVERSITY OF COLORADO · PI BOARDMAN, JASON D · 2017 to 2020
$681k
NIA NIH HHS RF1 AG064465NIA NIH HHS T32 AG052371NINDS NIH HHS R01 NS086933
6 · The paper itself

Abstract

Protein kinase B (PKB/AKT) is a central kinase involved in many neurobiological processes. AKT is expressed in the brain as three isoforms, AKT1, AKT2, and AKT3. Previous studies suggest isoform-specific roles in neural function, but very few studies have examined AKT isoform expression at the cellular level. In this study, we use a combination of histology, immunostaining, and genetics to characterize cell-type-specific expression of AKT isoforms in human and mouse brains. In mice, we find that AKT1 is the most broadly expressed isoform, with expression in excitatory neurons and the sole detectable AKT isoform in gamma-aminobutyric acid ergic interneurons and microglia. By contrast, we find that AKT2 is the sole isoform expressed in astroglia and is not detected in other neural cell types. We find that AKT3 is expressed in excitatory neurons with AKT1 but shows greater expression levels in dendritic compartments than AKT1. We extend our analysis to human brain tissues and find similar results. Using genetic deletion approaches, we also find that the cellular determinants restricting AKT isoform expression to specific cell types remain intact under

Indexed as

amygdalaastrocyteshippocampusinterneuronsmicroglia

Identifiers

PMID34296180
PMCPMC8223503
OpenAlexW3169500497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.